2005 International Marketing and Sales Management Training Program for Senior Management of the China National Biotec Corporation
The Research Institute for Asia and the Pacific (RIAP) recently designed and delivered a 4 day training program for Chinese Senior Management of the China National Biotec Corporation (CNBC) from the 5th October to the 10th of October 2005. With the objective of gaining an improved understanding of marketing and sales management strategies within the biotechnology sector. The delegates had the opportunity to engage with lecturers' from the University of Sydney as well as industry experts to obtain an insight into the Australian industry, allowing them to compare and contrast the differences in management experiences.
More photos
Topics of the Training Course include:
- Overview of the Australian Government, Political, Legal and Societal Structures.
- Overview on the Australian Biotech Industry.
- Biotech Industry - Market Analysis.
- Market Development .Strategy Formulation and Implementation.
- Sales Strategy Formulation.
- Implementation of Sales Strategy and Sales Channel Management.
- Sales Performance Management - KPI's and incentives
- International Brand Management.
- Infectious Disease Control Strategies.
Representatives from CNBC:
- Mr Bian Junfeng, Vice General Manager, CNBC.
- Mr Wang Jianhua, Department Manager, CNBC.
- Mr Li Xiangrong, Department Manager, CNBC.
- Mr Chen Huayun, Deputy Director, Changchun Institute of Biological Products.
- Mr Zhang Lu, Section Chief, Changchun Institute of Biological Products.
- Mr Wu Yonglin, Deputy Director, Changdu Institute of Biological Products.
- Ms Wang Jie, Section Chief, Changdu Institute of Biological Products.
- Mr Fu Daoxing, Vice General Manager, Chengdu Rongsheng Pharmaceuticals Co., Ltd.
- Mr Qin Jingguo, Assistant General Manager, Chengdu Rongsheng Pharmaceuticals Co., Ltd.
- Mr Wu Qiang, Vice General Manager, Lanzhou Institute of Biological Products.
- Mr Feng Duojia, Vice General Manager, CNBC.
- Mr Li Zhenfei, Department Manager, China National Scientific Instruments and Materials Im/Ex Corporation.
- Ms Luo Linyun, Department Manager, National Vaccine and Serum Institute.
- Mr Zhao Guojun, Vice General Manager, Beijing Tiantan Biological Products Co., Ltd.
- Mr Liu Xinjun, Assistant General Manager, Beijing Tiantan Biological Products Co., Ltd.
- Mr Zou Guangrong, Director, Wuhan Institute of Biological Products.
- Mr Yang Xiaoming, Deputy Director, Wuhan Institute of Biological Products.
- Mr Zhang Yang, Section Chief, Wuhan Institute of Biological Products.
- Mr Yang Zhongdong, Deputy Director, Shanghai Institute of Biological Products.
- Mr Wang Menglian, Assistant Director, Shanghai Institute of Biological Products.
- Mr Qiao Yanhong, Department Manager, China National Scientific Instruments and Material In/Ex Corporation.
- Mr Sun Zhao, Marketing Associate, China National Scientific Instruments and Material In/Ex Corporation.
- Ms Xie Bin, CNBC.
Speakers
RIAP would like to acknowledge the invaluable time and effort contributed by:
- Professor John Hearn, Deputy Vice Chancellor (Academic and International).
- Professor Merlin Crossley, School of Molecular and Microbial Biosciences.
- Dr Helen Nelson, The University of Sydney.
- Professor Michael Vitale, Australian Graduate School of Management, University of Sydney and University of NSW.
- Sergio Scrofani, Director of Business Development, AMRAD Corporation.
- Dr John Rose, Decision Research Asia: Global Marketing Partners.
- Simon Fifer, Decision Research Asia: Global Marketing Partners.
- Craig Newton, CEO, Cynata Pty Ltd.
- Michael Egan, CresaGen Ltd.
- Dr Terry Beed, Fellow of St Andrew's College in the University of Sydney.
